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progression of peritoneal sclerosis in such patients is associatedExpression of heat shock proteins 47 and 70 in the peritoneum
with deterioration of peritoneal ultrafiltration function.of patients on continuous ambulatory peritoneal dialysis.
Background. Peritoneal sclerosis, characterized by collagen
accumulation, is a serious complication in continuous ambula-
tory peritoneal dialysis (CAPD) therapy. Heat shock protein Continuous ambulatory peritoneal dialysis (CAPD)47 (HSP47) is a collagen-specific molecular chaperon and is
has been used in the treatment of end-stage renal failureclosely associated with collagen synthesis.
during the last two to three decades. Peritoneal sclerosisMethods. We determined the expression of HSP47 and HSP70
(nonspecific for collagen synthesis) by immunohistochemistry was first described in 1980 [1] and is one of the most
in peritoneal tissues of patients on CAPD. The tissue for colla- important complications of CAPD therapy. Especially,
gen III, a-smooth muscle actin (a-SMA), and CD68 (a marker some patients develop encapsulating peritoneal sclerosisfor macrophages) were also stained. Thirty-two peritoneal sam-
(EPS), a condition associated with high mortality [2, 3].ples were divided into three groups (group A1, 11 patients
Although it is still uncertain whether EPS is an advancedwho had no ultrafiltration loss; group A2, 9 patients who had
ultrafiltration loss; and group B, 12 specimens who had end- stage of peritoneal sclerosis, the characteristic pathologi-
stage renal disease prior to induction of CAPD. cal feature of EPS is marked peritoneal sclerosis [2].
Results. In group B, staining for HSP47, HSP70, and colla- Peritoneal sclerosis usually occurs in patients who have
gen III in peritoneal tissues was faint, and only a few cells were
been on peritoneal dialysis for several years [2], but itpositive for a-SMA and CD68. In contrast, HSP47, HSP70,
occasionally develops in patients who have been onand collagen III were expressed in areas of thickened connec-
tive tissues in fibrotic peritoneal specimens of CAPD patients. CAPD for as little as six months [4]. One of the character-
The expression level of HSP47, HSP70, collagen III, and istic pathological features of peritoneal sclerosis is a mas-
a-SMA and the number of CD68-positive cells in group A2 sive accumulation of collagen; however, the mechanism
were significantly higher than those in groups A1 and B. HSP47/
of development and the progression of peritoneal sclero-HSP70-positive cells were mesothelial cells, adipocytes, and
sis remain to be elucidated. Clinically, loss of ultrafiltra-a-SMA–positive myofibroblasts. Furthermore, the expression
level of HSP47 was significantly higher in peritoneal specimens tion is one of the most important problems in patients
from patients with refractory peritonitis than without it and with CAPD. The relationship between morphological
was significantly higher in patients with more than 60 months changes in the peritoneum of CAPD patients and ultra-
of CAPD therapy than that in patients with less than 60 months
filtration loss is also unclear.of CAPD.
Heat shock proteins (HSPs) are synthesized underConclusion. Our results indicate that CAPD therapy may
various forms of stress and are important in various phys-induce HSPs in the peritoneal tissue, and that peritonitis in
CAPD patients may be associated with the progression of iological and pathological processes [5]. HSPs are molec-
peritoneal sclerosis at least through HSP47 expression and ular chaperones responsible for protein processing and
chronic macrophage infiltration. Our data also suggest that the
protection against cellular injury by preventing inappro-
priate peptide interaction. Recent studies have demon-
strated that one HSP, a 47 kd HSP (HSP47), is involvedKey words: peritoneal ultrafiltration, sclerosis, end-stage renal failure,
collagen synthesis, fibroblasts. in collagen production. HSP47 is a collagen-binding stress
protein [6] and acts as a collagen-specific molecular chap-
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collagen type I and type III mRNAs during the progres- discontinuation of antibiotics. Refractory peritonitis was
defined as an episode associated with no clinical im-sion of rat experimental liver fibrosis [8]. Moreover, using
in situ hybridization, they also demonstrated that the provement five days after the commencement of appro-
priate antibiotic therapy. CAPD was also discontinueddistribution of HSP47 mRNA was similar to that of colla-
gen type I and type III mRNAs in the model of liver in patients of group A2 because of ultrafiltration failure.
One patient (number 14) of group A2 developed EPSfibrosis [8]. Similarly, in several renal diseases, including
renal interstitial fibrosis induced by unilateral ureteral with ileus. Serum levels of C-reactive protein were nega-
tive at the time of peritoneal biopsy in patients withobstruction [9], experimental mesangial proliferative
glomerulonephritis [10], age-related nephropathy [11], recurrent or refractory peritonitis episodes. The mean
duration of CAPD therapy in group A1 (53.5 6 40.8gentamicin nephrotoxicity [12], and human transplanted
kidney with fibrosis (abstract; Abe et al, J Am Soc months, 6 SD) was not different from that of group A2
(78.8 6 35.0 months). The mean age of patients of groupsNephrol 8:718A, 1997), the expression of HSP47 also
correlates with the degree of collagen expression. Fur- A1 (50.8 6 15.2) was not different from that of group
A2 (50.9 6 11.9 years). The mean number of episodesthermore, Sunamoto et al showed that antisense oligonu-
cleotides for HSP47 inhibited collagen synthesis in exper- of peritonitis in group A1 during CAPD therapy (3.4 6
3.4) was not different from that of group A2 (3.2 6 0.8).imental mesangial proliferative glomerulonephritis
induced by anti–Thy-1 antibody [13]. These findings sug- Table 2 shows the glucose concentration in dialysate
used in our patients. Peritoneal equilibration test (PET)gest that HSP47 probably plays an important role in
collagen synthesis in various disorders. was performed in nine patients. Four of nine patients of
group A2 showed type I membrane failure, and 5 of 11Like several other HSPs, HSP70 is induced by heat
shock, hyperthermia, ischemia, toxic chemicals, and patients in group A1 showed below average in PET.
Twelve peritoneal specimens obtained from the siteother environmental stresses, as well as during normal
cell growth [6]. It acts as a molecular chaperone that of insertion of the catheter for CAPD therapy prior to
CAPD were used as control (group B; Table 3). Themediates the correct assembly and localization of pro-
teins [14]. HSP70 has a different inducible regulatory mean age of patients of group B was 46.0 6 13.7 years,
which was not significantly different from that of groupmechanism from HSP47 [15] and is not associated with
collagen synthesis. To date, there are no data on the A. None of the patients in group B had previously been
on peritoneal dialysis or hemodialysis. The serum albu-expression of HSP47 and HSP70 in the peritoneal cavity.
In this study, using immunohistochemistry, we exam- min level was 3.50 6 0.38 mg/dL, 3.17 6 0.77 mg/dL and
3.74 6 0.25 mg/dL in groups A1, A2, and B, respectively.ined the expression of HSP47 and HSP70 in human peri-
toneal specimens from patients on CAPD. To our knowl- The level of serum albumin in group A2 was significantly
lower than in group B (P , 0.05).edge, this is the first report that shows that peritoneal
fibroblasts express HSP47 and that the expression level The study protocol was approved by the Human Ethics
Review Committee of Nagasaki University School ofof HSP47 appears to correlate with the degree of perito-
neal sclerosis. Medicine, and a signed consent form was obtained from
each subject.
METHODS Tissue preparation
Patients Biopsy specimens were carefully obtained from the
parietal peritoneum at the border of the anterior abdom-Thirty-two individuals were examined in this study
(Tables 1 and 2). Twenty peritoneal biopsies were ob- inal wall incision in elective or catheter-related opera-
tion, as described by Suassuna et al [17]. Harvested tis-tained from patients in whom CAPD had been discon-
tinued. The clinical data of these patients are summa- sues were fixed with 10% formalin and were embedded
in paraffin.rized in Table 1. CAPD patients were divided into two
groups according the presence or absence of ultrafiltra-
Immunohistochemistrytion loss: group A1 (N 5 11), representing those without
ultrafiltration loss, and group A2 (N 5 9), representing Paraffin-embedded tissue sections (4 mm thick) were
stained immunohistochemically using the avidin-biotinthose with ultrafiltration loss. CAPD was discontinued
in patients of group A1 because of renal transplantation, complex kit (Vectastain Elite ABC KIT; Vector Labora-
tories, Burlingame, CA, USA). Deparaffinized tissue sec-abdominal operation, or the refractory or recurrent in-
fectious peritonitis. “Recurrent” and “refractory” perito- tions were reacted with the following primary antibodies:
a monoclonal antibody against mouse HSP47 (StressGen,nitis were defined according to the recent report of Pira-
ino [16]. Recurrent peritonitis was defined as a second Victoria, Canada), which reacts with human HSP47 [18];
monoclonal antibody against human a-smooth muscle ac-episode of peritonitis caused by an organism identical
to that causing the first episode within two weeks of tin (a-SMA; Dako, Glostrup, Denmark), used as a marker
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Table 1. Clinical data of group A patients treated with continuous ambulatory peritoneal dialysis
Duration No. of UF BUN Cr TP Alb
of CAPD Causes of catheter episodes of volume
No. Age/sex months removal peritonitis mL/day mg/dL
Group A1
1 30/F 16 renal transplantation 0 1,000 47.5 9.2 6.1 3.9
2 36/M 31 renal transplantation 0 1,400 27 2.7 5.2 3.4
3 54/M 18 abdominal operation 1 1,000 64 7.9 5.8 3.5
4 70/F 67 recurrent peritonitis 8 1,200 71 12.2 6.9 3.6
5 60/M 64 cerebral infarction 3 700 36 6.8 6.1 3.4
6 60/F 20 tunnel infection 0 1,000 43 14.2 5.1 2.6
7 77/M 160 refractory peritonitis 2 1,000 24 7.2 5.5 3.1
8 39/M 53 tunnel infection 5 1,000 91 11.2 5.6 3.7
9 40/M 66 recurrent peritonitis 8 800 57 10.9 6.6 3.8
10 55/F 62 tunnel infection 2 900 33 5.2 5.9 3.7
11 38/M 31 tunnel infection 5 1,000 69 12.5 5.8 3.8
Group A2
12 41/F 49 UF loss 2 470 81 9.9 6.1 3.1
13 42/F 88 UF loss 3 300 71 11.6 5.9 3.1
14 44/F 88 UF loss 3 0 70 4.5 4.6 2.8
15 75/M 59 UF lossa 2 400 68 9.3 6.1 3.1
16 50/M 60 UF lossa 4 0 40 9.1 5.4 2.9
17 40/M 38 UF loss 4 450 89 11.9 8.1 5.1
18 47/F 132 UF loss 4 300 47 6.5 5.9 2.9
19 55/M 60 UF lossa 4 300 107 11.1 5.6 2.3
20 64/M 135 UF loss 3 400 42 10.1 6.6 3.2
Age is in years. The cause of CRF was chronic glomerulonephritis in all patients. Abbreviations are: UF loss, ultrafiltration loss; TP, total protein; Alb, serum
albumin.
a These group A2 patients had refractory or recurrent peritonitis episodes
for myofibroblasts [19]; monoclonal antibody against
CD68 (Dako), used as a marker for macrophages/mono-
cytes; and monoclonal antibody against human type IIITable 2. Glucose concentration of dialysate and results of the
peritoneal equilibration test (PET) in group A patients collagen (Fuji Chemical Co., Tokyo, Japan). Because
several HSPs are expressed in a variety of tissues underCAPD menu
various forms of stress, we also stained the tissues for
glucose concentration (%),
HSP70 using a monoclonal antibody against HSP70volume (L), 3 times
PET category
D/D0 D/PCr (StressGen). Negative control studies were performed
Group A1 by using irrelevant monoclonal antibodies of the same
1 1.5, 2 34 LA LA subclass, nonspecific mouse IgG1 (Dako) and IgG22 1.5, 2 33/2.5, 2 31 L L
(Dako) instead of primary antibodies, which showed no3 1.5, 2 33/2.5, 2 31 L L
4 1.5, 2 32/2.5, 2 32 LA LA positive cells (data not shown).
5 1.5, 2 32/2.5, 2 32 LA LA To identify myofibroblasts among the population of6 1.5, 2 33/2.5, 2 31 NA NA
cells positive for HSP47 in peritoneal specimens, double7 1.5, 2 33/2.5, 2 31 NA NA
8 2.5, 2 34/1.5, 2 31 NA NA immunolabeling for HSP47 and a-SMA was performed
9 2.5, 1.5 34 NA NA
with some modification using the methods described by10 1.5, 2 32/2.5, 232 NA NA
11 2.5, 2 34 NA NA Furusu et al [20]. Briefly, deparaffinized peritoneal sec-
Group A2 tions were incubated with blocking serum and anti–a-
12 1.25, 2 32/4.25, 2 32 HA H
SMA antibody. Then the sections were washed with13 2.5, 2 34 HA HA
14 4.0, 2 34 NA NA phosphate-buffered saline and incubated with the biotin-
15 2.5, 2 34 HA HA ylated antimouse antibody. After washing, sections were16 2.5, 2 34 HA HA
incubated with alkaline phosphatase-conjugated avidin17 2.5, 2 34/1.35, 2 31 NA NA
18 2.5, 2 34 NA NA (Vector), following a reaction with BCIP/NBT (Dako).
19 2.5, 2 34/1.5, 2 31 NA NA Cells positive for a-SMA were stained in blue color.20 2.5, 2 32/4.25, 2 32 NA NA
After staining for a-SMA, tissue sections were stained
Abbreviations are: D/D0, 4 h/0 h dialysate glucose concentration ratio; D/PCr,
dialysate/plasma creatinine ratio; L, low; LA, low average; HA, high average; H, for HSP47 using the avidin-biotin complex kit, as de-
high; NA, not available. scribed earlier in this article. HSP47 protein was stained
brown.
To estimate the signal intensity for each protein semi-
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Table 3. Clinical data of group B patients treated with continuous ambulatory peritoneal dialysis
BUN Cr TP Alb
Age Cause of
Case no. years Sex CRF mg/dL
1 24 F CGN 57 8.2 6.0 3.9
2 24 M CGN 70 8.7 5.4 3.5
3 41 M CGN 71 8.1 6.2 3.8
4 60 M CGN 67 10.1 5.6 3.8
5 64 M NS 71 7.1 5.9 3.8
6 34 M CGN 76 9.9 6.4 4.2
7 41 M CGN 87 8.5 5.5 3.5
8 58 F CGN 74 9.5 6.0 3.7
9 58 M CGN 70 8.9 5.6 3.2
10 44 M CGN 118 17.4 6.2 3.8
11 55 M CGN 87 8.1 6.7 3.9
12 49 F CGN 92 7.2 6.5 3.8
Mean6SD 46.0613.7 78.3615.9 9.3162.7 6.060.4 3.760.2
Abbreviations are: CGN, chronic glomerulonephritis; NS, nephrotic syndrome.
quantitatively, image analysis of stained sections was morphonuclear cells were observed even in specimens
from patients with tunnel infection and recurrent or re-performed using an Olympus Image Analyzer system.
The image was transformed into a matrix of 1280 3 1000 fractory peritonitis episodes.
pixels, and the voltage signal at each pixel was converted
Immunohistochemistryto 1 of 256 intensity gray levels in proportion to the
colorimetric staining. By summation of the values of Peritoneal sections obtained prior to CAPD. A weak
pixels in five fields contained submesothelial region at immunoreactivity for HSP47 was observed in the subme-
3 200 magnification, we could determine the signal den- sothelial region (Fig. 2A, B). Almost all mesothelial cells
sity for HSP47, HSP70, a-SMA, and type III collagen. were negative for HSP47, although some occasionally
Fat tissue, vessel, and muscle were excluded in the field. expressed HSP47 (Fig. 2C). HSP70 and type III collagen
Then the density of these markers per 0.14 mm2 were were hardly detected in peritoneal specimens obtained
compared among the three groups. The number of prior to CAPD therapy (Fig. 2D, E). No cells positive
CD68-positive cells was also counted in the same field for CD68 were detected (Fig. 2F), and staining for
at 3200 magnification. a-SMA was present only in blood vessel walls (Fig. 2G).
Peritoneal tissue from CAPD patients. In peritoneal tis-
Statistical analysis sues of patients of group A1, HSP47 and type III collagen
were expressed in the thickened connective tissue of theData were expressed as mean 6 SD. Differences
among groups were examined for statistical significance submesothelial region (Fig. 3A, B, E). The remaining
mesothelial cells strongly expressed HSP47 (Fig. 3C).using one-way analysis of variance with Scheffe’s F-test.
Correlation coefficients were tested for significance using HSP70 was also expressed in the thickened submesothel-
ial region (Fig. 3D) and mesothelial cells, and CD68-the Spearman rank correlation test. A P value of less than
0.05 denoted the presence of a statistically significant positive cells were occasionally detected (Fig. 3F). Many
cells were positive for a-SMA in the submesothelial areadifference.
(Fig. 3G). In group A2, peritoneal tissues showed in-
tense immunoreactivity for both HSP47 and HSP70
RESULTS (Fig. 4A–C). Intense staining for type III collagen was
Hematoxylin-eosin staining also observed in the area (Fig. 4D). Moreover, several
cells positive for CD68 were present in markedly thick-Histologic examination of hematoxylin-eosin–stained
ened areas with abundant proliferation of collagen fiberssections of group B showed a monolayer of mesothelial
(Fig. 4E). a-SMA was expressed very strongly in thecells covering the surface of the peritoneum (Fig. 1A,
markedly thickened submesothelial area (Fig. 4F).B), as well as the presence of small blood vessels scat-
In order to identify the type of cells that expressedtered among collagen fibers. In group A1 patients, the
peritoneal tissue was partly thickened by proliferation HSP47, we performed immunohistochemistry for HSP47
and a-SMA, a marker for activated fibroblasts (myofi-of collagen fibers (Fig. 1C). In group A2, mesothelial
cells were mostly detached, and peritoneal tissue was broblasts) using serial sections (Fig. 5). Moreover, for
precise localization of HSP47 and a-SMA, we performedmarkedly thickened by proliferation of collagen fibers
with occasional hyalinous changes (Fig. 1D, E). No poly- double staining for these markers (Fig. 6). From the
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Fig. 1. Hematoxylin-eosin staining of representative samples of perito-
neal tissues. (A) Peritoneal tissue from patients prior to continuous
ambulatory peritoneal dialysis (CAPD) therapy. Note that the perito-
neal surface is covered with a monolayer of mesothelial cells (3100).
Small blood vessels are found scattered among collagen fibers. (B)
High-power field of sections shown in 1A. Mesothelial cells are clearly
observed on the surface of the peritoneum (3400). (C ) Tissues of group
A1 patients (without ultrafiltration loss). The submesothelial region is
thickened by proliferation of collagen fibers (3100). (D) Tissues of
group A1 patients (without ultrafiltration loss). Some specimens show
more thickened mesothelial regions, but no hyalinous changes are ob-
served (340). (E) Peritoneal tissues of group A2 (patients with ultrafil-
tration loss). Mesothelial cells are mostly detached, and the peritoneal
tissue is markedly thickened by irregular proliferation of collagen fibers.
Note the occasional hyalinous changes of collagen fibers (*; 3100).
results of staining in serial sections (Fig. 5) and double gen III, whereas others were stained for only one of
these proteins (data not shown). Figure 8 shows thatstaining (Fig. 6), the majority of cells that expressed
a-SMA were also positive for HSP47. However, the dis- HSP47 and collagen III were also expressed in adipo-
cytes present in the fat tissue. Moreover, adipocytes weretribution of HSP70-positive cells was not always identical
to those positive for a-SMA. A comparison between stained for HSP70 (data not shown).
Table 4 compares the level of expression of HSP47,localization of HSP47 and cells positive for CD68, a
marker for macrophages, in serial sections showed that HSP70, collagen III, a-SMA, and CD68 among the three
groups. Because fat tissue, vessel, and muscle were ex-HSP47 was expressed in the area containing many infil-
trating macrophages (Fig. 7). A comparison of expres- cluded in the selected areas, almost all signal intensity
of HSP47, HSP70, collagen III, a-SMA shown here rep-sion of HSP47 and type III collagen in adjacent sections
showed that some cells were stained for HSP47 and colla- resented the expression in collagen fibers. The expres-
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Fig. 2 Immunohistochemistry for heat shock protein 47 (HSP47), type
III collagen, HSP70, CD68, and a-smooth muscle actin (a-SMA) in
peritoneal tissues of patients prior to CAPD (group B). (A) Note the
faint but significant staining for HSP47. (B ) High-power field of 2A
showing a spindle-type cell positive for HSP47 (arrow head). (C ) Note
that mesothelial cells are almost negative (arrow), but some cells are
positive (arrow heads). Type III collagen (D) and HSP70 (E ) are hardly
detected in the peritoneal tissue prior to CAPD. (F ) Note the lack of
cells positive for CD68. (G) Note also that only blood vessels are
positive for a-SMA. Original magnification: A, D, E, F and G, 3100;
B and C, 3400.
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Fig. 3. Immunohistochemistry of peritoneal tissues of group A1 pa-
tients (CAPD patients without ultrafiltration loss). (A) HSP47 was
expressed in thickened connective tissue in the submesothelial region.
(B ) High-power field of 3A demonstrating spindle-typed cells positive
for HSP47. (C ) Almost all remaining mesothelial cells are strongly
positive for HSP47 (arrows). (D) Note that HSP70 is also expressed in
spindle-typed cells in thickened submesothelial regions. (E) Note also
the positive expression of type III collagen. (F ) CD68-positive cells are
occasionally detected (arrows). (G) Cells in the submesothelial area
are stained for a-SMA. Original magnification: A, D, E and F, 3100;
B, 3200; C, 3400.
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Fig. 4. Immunohistochemistry of peritoneal tissues of group A2 patients (CAPD patients with ultrafiltration loss). Peritoneal tissues show intense
expression of HSP47 and HSP70 (A–C ). Type III collagen is also strongly stained in the area (D). (E ) Many cells positive for CD68 are present
in the markedly thickened area with proliferation of collagen fibers. a-SMA is abundantly expressed in the markedly thickened submesothelial
area (F, shown by arrows) as well as blood vessels. Original magnification: A, C, D, E, and F, 3100; B, 3200.
sion level of HSP47, HSP70, and collagen III was signifi- Because peritonitis may stress the peritoneum, we also
examined the effect of peritonitis present at the time ofcantly higher in groups A1 and A2 than in group B (P ,
0.01; Table 4). Furthermore, the expression levels of peritoneal collection on histochemical alteration. The
levels of expression of HSP47 and CD68 in peritonealHSP47, HSP70, collagen III, and a-SMA in group A2
were significantly higher than in group A1, as shown in tissues from 6 patients with recurrent or refractory peri-
tonitis episodes were significantly higher than in tissuesFigure 4. On the other hand, a significantly higher level
of CD68 expression was present in the peritoneal tissue from 14 patients without such episodes (P , 0.01 and P ,
0.05, respectively), whereas the expressions of HSP70,of group A2 than in groups A1 and B.
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Fig. 5. Immunohistochemistry for HSP47 and a-SMA in serial sections
Fig. 6. Double immunostaining demonstrating HSP47 (brown) andfrom group A2 patients. To identify the relationship between a-SMA–
a-SMA (blue) in the same section. To determine the presence of a-SMA–positive cells (myofibroblasts) and cells positive for HSP47, immunohis-
positive cells (myofibroblasts) among cells positive for HSP47, doubletochemistry for HSP47 (A) and a-SMA (B ) was performed in serial
immunolabeling for HSP47 and a-SMA was performed in the samesections. Note that the majority of cells that express a-SMA are also
section. Note that a-SMA–positive cells in the peritoneal tissue are alsopositive for HSP47, suggesting that HSP47 is mainly expressed in myo-
stained with anti-HSP47 antibody. Original magnification: A, 3200; andfibroblasts. Blood vessel wall (V) is stained for a-SMA, not HSP47.
B, 3400.Original magnification: A and B, 3400.
specimens of all groups (r 5 0.639, 0.743, and 0.496,
a-SMA, and collagen III were not significantly different respectively; Table 5). Finally, we examined the relation-
in the two groups. Furthermore, the expression of HSP47, ship between the duration of CAPD therapy and the
collagen III, and CD68, but not HSP70 nor a-SMA, corre- expression of HSP47, HSP70, a-SMA, CD68, and colla-
lated with the frequency of peritonitis episodes [r 5 0.615, gen III in peritoneal tissues. Because the mean duration
0.646 (Fig. 9), 0.547, respectively, P , 0.05]. from the beginning to the development of EPS is about
60 months in Japanese patients with EPS [21], we dividedRelationship between expression of heat
our patients into those with CAPD therapy for more orshock proteins and cells positive for collagen
less than 60 months. In peritoneal tissue from patientstype III, a-smooth muscle actin, and CD68 in
with more than 60 months of CAPD therapy, the degreeperitoneal specimens
of HSP47 and collagen III expression was significantly
There was a positive correlation between the expres- higher than in patients with less than 60 months of CAPD
sion of HSP47 and type III collagen in peritoneal speci- (P 5 0.026 and P 5 0.043, respectively; Fig. 10). The
mens from the three groups (r 5 0.819; Table 5). The expression of HSP70 and a-SMA did not correlate with
expression of HSP47 also positively correlated with that the duration of CAPD therapy.
of HSP70 and a-SMA (r 5 0.676 and 0.765, respectively;
Table 5). In addition, the level of HSP47 in the perito-
DISCUSSIONneum also correlated with CD68-positive cell counts (r 5
0.600). Furthermore, the expression of HSP70 correlated Using immunohistochemistry, we have demonstrated
in this study that HSP47 and HSP70 are expressed inwith that of collagen III, a-SMA, and CD68 in peritoneal
Shioshita et al: HSP47 and HSP70 in peritoneal sclerosis628
Fig. 7. Immunohistochemistry for HSP47 (A) and CD68 (B) in serial Fig. 8. Immunohistochemistry for HSP47 and collagen III in peritoneal
sections. HSP47 is expressed in the area where many cells positive for adipose tissues from group A2 patients treated with CAPD. (A) Adipo-
CD68 have infiltrated the peritoneum (arrows). Original magnification: cytes are stained for HSP47. (B) Note that adipocytes in fat tissues are
A and B, 3200. positive for collagen III. Original magnification: A and B, 3100.
Table 4. Comparison of signal density in the three groups examinedareas of thickened connective tissue in sclerotic perito-
in the present studyneal specimens of CAPD patients. The expression of
Antibody Group B Group A1 Group A2HSP47, a collagen-specific stress protein, correlated with
the frequency of peritonitis episodes. To our knowledge, HSP47 2.1361.75 7.6764.55a 19.5966.50ab
HSP70 2.3461.29 7.1264.35a 12.0566.70abthis is the first report that demonstrates the expression
Collagen III 2.0061.61 13.4464.90a 24.5865.54abof HSPs in human peritoneal specimens obtained from a-SMA 0.2260.10 1.8261.49 8.3466.96ab
CAPD patients. CD68 0.7060.17 3.9660.75 21.4763.24ab
Various stress factors are known to induce the expres- Images were transformed into a matrix of 1280 3 1000 pixels, and the voltage
signal at each pixel was converted to 1 of 256 intensity gray levels in proportionsion of HSPs. In this study, we examined two types of
to the colorimetric staining. Data are mean 6 SD (3106) of the sum pixel values
HSPs: HSP47, which is associated with collagen synthe- for HSP47, HSP70, a-SMA and type III collagen. The number of CD68 positive
cells was counted per 0.14 mm2 at a 3 200 magnification. Differences betweensis, and HSP70, which is not associated with collagen
different groups were tested for statistical significance using one-way analysis of
synthesis. The expression of HSP70 as well as that of variance with Scheffe’s F-test.
a P , 0.01, compared with group BHSP47 in CAPD patients (groups A1 and A2) was higher
b P , 0.01, compared with group A1
than in patients with chronic renal failure before CAPD
treatment (group B). This finding suggests that CAPD
itself may cause some stress on the peritoneal tissue of
CAPD patients. In fact, our results showed that HSP47 contamination in the dialysate [2, 3], acetate dialysate
and HSP70 were also expressed even in the peritoneum [1–3], and the use of antiseptics [3, 22]. Moreover, glyca-
of a patient without peritonitis episode who had been tion [23] and carbonyl modification (abstract; Horie et
treated with CAPD for only 16 months. Previous studies al, J Am Soc Nephrol 9:1444A, 1998) of peritoneal tissue
indicated that many factors might be involved in the were recently reported in CAPD patients. In this regard,
it is possible that the long-term use of CAPD therapydevelopment of peritoneal sclerosis, including endotoxin
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Fig. 10. Expression levels of HSP47 and collage III are influenced by
the duration of CAPD therapy. Data are mean 6 sd of the sum of
pixel values of (3106) HSP47 and collagen III. The degree of HSP47
and collagen III expression was significantly higher in peritoneal tissues
from patients with more than 60 months of CAPD therapy (j) com-
pared with that in patients with less than 60 months of CAPD (h).
Differences between data of different groups were tested for statistical
significance using one-way analysis of variance with Scheffe’s F-test.
*P 5 0.026; **P 5 0.043.
of high glucose concentration in dialysate and acidic dial-
ysate on HSP47 and HSP70 expression are also impor-
tant issues. Further studies are warranted to investigate
the pathophysiological effects of CAPD per se, including
new peritoneal dialysis solution and long-term duration
of CAPD therapy on the peritoneum.
Our results showed a high level of HSP47 expression,
but not that of HSP70, in peritoneal tissues of CAPDFig. 9. Correlation between expression of HSP47, collagen III, and
patients with recurrent or refractory peritonitis episodes.frequency of peritonitis. Ordinate data represent the sum of pixel values
of (3106) HSP47 (A) and collagen III (B). Spearman rank correlation. Moreover, the level of HSP47 expression correlated with
Note the correlation positive between expression of HSP47 and collagen the frequency of peritonitis episodes. Although the num-III with the frequency of peritonitis episodes (r 5 0.615, 0.646, respec-
ber of patients in this study is too small to draw a definitetively, P , 0.05).
conclusion, our results indicate that peritonitis is a strong
inducer of HSP47. Acute inflammation may induce HSPs
in the peritoneum; however, the serum C-reactive pro-Table 5. Correlation between the expression of HSPs and that of
type III collagen, a-SMA and the number of CD68-positive cells tein was negative in all patients, and no polymorphonu-
clear cells were present in the peritoneum, irrespectiveHSP47 HSP70 Collagen III a-SMA CD68
of the history of peritonitis. Therefore, we suggest that
HSP47 — 0.676a 0.819a 0.765a 0.600a
peritonitis may exert a chronic effect on the peritoneum,HSP70 0.676a — 0.639b 0.743a 0.496b
ultimately leading to peritoneal sclerosis. The preciseData represent the Spearman rank correlation coefficients between paired
variables. The expression of HSP47 correlated positively with that of HSP70, mechanism of the induction of HSP47 is uncertain, but
collagen III, a-SMA, and number of CD68 positive cells in peritoneal specimens. in our study, more macrophage infiltration was observedThe expression of HSP70 also correlated positively with that of collagen III,
a-SMA, and number of CD68-positive cells. in the peritoneum of patients with recurrent or refractory
a P , 0.01, b P , 0.05 peritonitis episodes. It is possible that increased levels
of cytokines and growth factors secreted by macrophages
may be involved in HSP47 expression [25, 26]. Clinically,
Rubin, Herrera, and Collins also demonstrated a goodrepresents a risk factor for the development of peritoneal
correlation between the number of peritonitis episodessclerosis [2, 4, 21, 24]; however, we could not identify the
and histologic changes in the peritoneum of CAPD au-exact effect of CAPD therapy itself on the progression
topsies [27]. With regard to the factors associated withof peritoneal sclerosis because the number of patients
without peritonitis was too small in this study. The effects induction of HSP47, a few reports have suggested that
Shioshita et al: HSP47 and HSP70 in peritoneal sclerosis630
malnutrition is involved in the expression of some HSPs, nation of HSP47 mRNA in the peritoneum of CAPD
patients should be performed in future studies.such as HSP60 and HSP70 [28, 29]. Because serum albu-
In conclusion, the results of this study demonstratemin concentrations in patients of group A2 were lower
that the sclerotic peritoneal tissues of CAPD patientsthan in groups A1 and B, it is also possible that malnutri-
overexpress HSP47 and HSP70 in a-SMA–positive myo-tion or underdialysis may have some effect on HSP47
fibroblasts and mesothelial cells, as well as adipocytes.expression. Further studies are necessary to identify the
We also show that the progression of peritoneal sclerosisprecise mechanism of HSP47 induction in the peritoneal
correlates with deterioration of peritoneal ultrafiltrationtissue of CAPD patients.
function in such patients. We propose that peritonitisWhat are the functional consequences of progression
and long-term CAPD therapy are associated with theof peritoneal sclerosis? Only a few studies have exam-
progression of peritoneal sclerosis, at least throughined the effect of structural changes in the peritoneum
HSP47 expression. Understanding of the mechanismson ultrafiltration loss. Honda et al reported three CAPD
that regulate HSPs expression may be of potential thera-patients with ultrafiltration loss who exhibited a variety
peutic value in patients with peritoneal sclerosis.of vascular changes, including deposition of collagen IV
and laminin and severe fibrosis and hyalinization [30].
ACKNOWLEDGMENTSIn the present study, CAPD patients with ultrafiltration
Part of this study was supported by a Research Grant for Progressiveloss showed more severe hyalinization of the thickened
Renal Disease from the Specially Selected Disease by the Ministry ofperitoneum, overexpression of HSP47, collagen III and
Health and Welfare Research Project and a Baxter PD Research Fund.
macrophage infiltration than those without functional The authors thank Mr. Masahiro Harada for technical assistance.
loss. The high degree of macrophage infiltration in the
Reprint requests to Masanobu Miyazaki, M.D., The Second Depart-peritoneum of patients with ultrafiltration loss suggests
ment of Internal Medicine, Nagasaki University School of Medicine,
that inflammation as well as peritoneal sclerosis may 1-7-1 Sakamoto, Nagasaki 852-8521, Japan.
E-mail: msnbmiya-ngs@umin.ac.jpbe associated with the loss of peritoneal ultrafiltration
properties. Moreover, considering the fact that macro-
REFERENCESphage-derived cytokines and growth factors, including
transforming growth factor-b [31, 32] and platelet- 1. Gandhi VC, Humayun HM, Ing TS, Daugirdas JT, Jablokow
VR, Iwaysuki S, Geis WP, Hano JE: Sclerotic thickening of thederived growth factor [33], enhance the differentiation
peritoneal membrane in maintenance peritoneal dialysis patients.of fibroblasts into myofibroblasts, it is possible that infil- Arch Intern Med 140:1201–1203, 1980
trated macrophages in the peritoneum are closely in- 2. Afthentopouls IE, Passadakis P, Oreopoulos DG: Sclerosing
peritonitis in continuous ambulatory peritoneal dialysis patients:volved with increased number of myofibroblasts, leading
One center’s experience and review of the literature. Adv Ren
to the progression of peritoneal sclerosis via HSP47 ex- Replace Ther 5:157–167, 1998
3. Dobbie JW: Pathogenesis of peritoneal fibrosing syndromes (scle-pression. It is possible that the progression of peritoneal
rosing peritonitis) in peritoneal dialysis. Perit Dial Int 12:14–27,sclerosis may be associated with ultrafiltration loss in
1992
patients on CAPD. 4. Oules R, Challah S, Brunner P: Case-control study to determine
the cause of sclerosing peritoneal disease. Nephrol Dial TransplantIn the present study, we demonstrate that cells positive
3:66–69, 1988for HSP47 are a-SMA–positive myofibroblasts, meso-
5. Morimoto RI, Tissieres A, Georgopoulos C: The Biology of Heat
thelial cells, and adipocytes. Although we did not provide Shock Proteins and Molecular Chaperones. Cold Spring Harbor,
Cold Spring Harbor Laboratory Press, 1994, pp 1–30a direct evidence that cells positive for HSP47 synthe-
6. Nagata K, Saga S, Yamada KM: A major collagen-binding proteinsized collagen by in situ hybridization, taken together of chick embryo fibroblasts is a novel heat shock protein. J Cell
with the results of in situ hybridization reported by Ma- Biol 103:223–229, 1986
7. Nakai A, Satoh M, Hirayoshi K, Nagata K: Involvement of thesuda et al [8], where the distribution of HSP47 mRNA
stress protein HSP47 in procollagen processing in the endoplasmicwas similar to that of collagen type I and type III mRNAs reticulum. J Cell Biol 117:903–914, 1992
and other previous studies [6, 7], our results suggest that 8. Masuda H, Fukumoto M, Hirayoshi K, Nagata K: Coexpression
of the collagen-binding stress protein HSP47 gene and the a1 (I)HSP47-positive cells are closely associated with collagen
and a1 (III) collagen genes in carbon tetrachloride-induced rat
production. This is consistent with the results of in vitro liver fibrosis. J Clin Invest 94:2481–2488, 1994
9. Moriyama T, Kawada N, Ando A, Yamauchi A, Horio M, Na-studies showing that peritoneal fibroblasts [34], mesothe-
gata K, Imai E, Hori M: Up-regulation of HSP47 in the mouselial cells [35], and adipocytes [36] are capable of produc-
kidneys with unilateral ureteral obstruction. Kidney Int 54:110–119,
ing collagen. Because mesothelial cells are detached 1998
10. Razzaque MS, Taguchi T: Collagen-binding heat shock proteinfrom sclerotic peritoneal tissue and the location of these
(HSP) 47 expression in anti-thymocyte serum (ATS)-induced glo-three cells is different, we believe that these cells may merulonephritis. J Pathol 183:24–29, 1997
be involved in the progression of peritoneal sclerosis 11. Razzaque MS, Shimokawa I, Nazneen A, Higami Y, Taguchi T:
Age-related nephropathy in the Fischer 344 rat is associated withthrough a complex network. In this regard, the expres-
overexpression of collagens and collagen-binding heat shock pro-sion of HSP47 detected by immunohistochemistry does tein 47. Cell Tissue Res 293:471–478, 1998
12. Cheng M, Razzaque MS, Nazneen A, Taguchi T: Expression ofnot always indicate protein synthesis, and hence, exami-
Shioshita et al: HSP47 and HSP70 in peritoneal sclerosis 631
the heat shock protein 47 in gentamicin-treated rat kidneys. Int J 24. Rigby RJ, Hawley CM: Sclerosing peritonitis: The experience in
Australia. Nephrol Dial Transplant 13:154–159, 1998Exp Pathol 79:125–132, 1998
25. Yamamura I, Hirata H, Hosokawa N, Nagata K: Transcrip-13. Sunamoto M, Kuze K, Tsuji H, Ohishi N, Yagi K, Nagata K,
tional activation of the mouse HSP47 gene in mouse osteoblastKita T, Doi T: Antisense oligonucleotides against collagen-binding
MC3T3-E1 cells by TGF-beta 1. Biochem Biophys Res Communstress protein HSP47 suppress collagen accumulation in experi-
244:68–74, 1998mental glomerulonephritis. Lab Invest 78:967–972, 1998
26. Takahashi K, Kubo T, Goomer RS, Amiel D, Kobayashi K, Iman-14. Welch WJ: Mammalian stress response: Cell physiology, structure/
ishi J, Teshima R, Hirasawa Y: Analysis of heat shock proteinsfunction of stress proteins, and implications for medicine and dis-
and cytokines expressed during early stages of osteoarthritis in aease. Physiol Rev 72:1063–1081, 1992
mouse model. Osteoarthritis Cartilage 5:321–329, 199715. Lete Z, Engel S, Krone PH: Hsp47 and hsp70 gene expression
27. Rubin J, Herrera GA, Collins D: An autopsy study of the perito-is differentially regulated in a stress- and tissue-specific manner in
neal cavity from patients on continuous ambulatory peritonealZebrafish embryos. Dev Genet 21:123–133, 1997
dialysis. Am J Kidney Dis 18:97–102, 199116. Piraino B: Peritonitis as a complication of peritoneal dialysis. J Am
28. Ehrenfried JA, Evers BM, Chu KU, Townsend CM Jr, Thomp-Soc Nephrol 9:1956–1964, 1998
son JC: Caloric restriction increases the expression of heat shock17. Suassuna JH, Neves FC, Hartney RB, Ogg CS, Cameron JS:
protein in the gut. Ann Sung 223:592–597, 1996Immunohistochemical studies of the peritoneal membrane and
29. Heydari AR, You S, Takahashi R, Gutsmann A, Sarge KD,infiltrating cells in normal subjects and in patients on CAPD. Kid-
Richardson A: Effect of caloric restriction on the expression ofney Int 46:443–454, 1994
heat shock protein 70 and the activation of heat shock transcription18. Sauk JJ, Norris K, Moehring J, Foster RA, Somerman MJ: The
factor 1. Dev Genet 18:114–124, 1996expression of colligin/hsp47 after stress in human periodontal fi-
30. Honda K, Nitta K, Horita S, Yumura W, Nihei H: Morphologicalbroblast in vitro. Arch Oral Biol 35:645–651, 1990
changes in the peritoneal vasculature of patients on CAPD with19. Darby I, Skalli O, Gabbiani G: a-smooth muscle actin is tran- ultrafiltration failure. Nephron 72:171–176, 1996siently expressed by myofibroblasts during experimental wound 31. Desmouliere A, Geinoz A, Gabbiani F, Gabbiani G: Trans-healing. Lab Invest 63:21–29, 1990 forming growth factor-b-induced a-smooth muscle actin expres-
20. Furusu A, Miyazaki M, Abe K, Tsukasaki S, Shioshita K, Sasaki sion in granulation tissue myofibroblasts and in quiescent and grow-
O, Miyazaki K, Ozono Y, Koji T, Harada T, Sakai H, Kohno ing cultured fibroblasts. J Cell Biol 122:103–111, 1993
S: Expression of endothelial and inducible nitric oxide synthase 32. Mattey DL, Dawes PT, Nixon NB, Slater H: Transforming
in human glomerulonephritis. Kidney Int 53:1760–1768, 1998 growth factor beta 1 and interleukin 4 induced alpha smooth muscle
21. Nomoto Y, Kawaguchi Y, Kubo H, Hirano H, Sakai S, Kurokawa actin expression and myofibroblast-like differentiation in human
K: Sclerosing encapsulating peritonitis in patients undergoing con- synovial fibroblasts in vitro: Modulation by basic fibroblast growth
tinuous ambulatory peritoneal dialysis: A report of the Japanese factor. Ann Rheum Dis 56:426–431, 1997
sclerosing encapsulating peritonitis study group. Am J Kidney Dis 33. Tang WW, Van GY, Qi M: Myofibroblast and alpha 1 (III) colla-
28:420–427, 1996 gen expression in experimental tubulointerstitial nephritis. Kidney
22. Lo WK, Chan KT, Leung ACT, Pang SW, Tse CY: Sclerosing Int 51:926–931, 1997
peritonitis complicating prolonged use of chlorhexidine in alcohol 34. Breborowicz A, Patrikarea A, Martis L, Oreopoulos DG: Ef-
in the connection procedure for continuous ambulatory peritoneal fect of the dialysate effluent from CAPD patients on peritoneal
dialysis. Perit Dial Int 2:166–172, 1991 mesothelial cells and fibroblasts. Adv Perit Dial 10:230–234, 1994
23. Nakayama M, Kawaguchi Y, Yamada K, Hasegawa T, Takazoe 35. Stylianou E, Jenner LA, Davis M, Coles GA, Williams JD:
K, Katoh N, Hayakawa H, Osaka N, Yamamoto H, Ogawa A, Isolation, culture and characterization of human peritoneal meso-
Kubo H, Shigematsu T, Sakai O, Horiuchi S: Immunohistochemi- thelial cells. Kidney Int 37:1563–1570, 1990
cal detection of advanced glycosylation end-products in the perito- 36. Cryer A, Van RL: Characterization of the collagen types synthe-
neum and its possible pathophysiological role in CAPD. Kidney sized by human and rat adipocyte precursors in vitro. Eur J Clin
Invest 12:235–238, 1982Int 51:182–186, 1997
